Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 31

1.

Treatment with insulin detemir or NPH insulin in children aged 2-5 yr with type 1 diabetes mellitus.

Thalange N, Bereket A, Larsen J, Hiort LC, Peterkova V.

Pediatr Diabetes. 2011 Nov;12(7):632-41. doi: 10.1111/j.1399-5448.2010.00750.x. Epub 2011 Mar 21.

PMID:
21418455
[PubMed - indexed for MEDLINE]
2.

Insulin omission. A troubling trend among adolescent girls.

Haagen BF.

J Psychosoc Nurs Ment Health Serv. 2011 Feb;49(2):6-7. doi: 10.3928/02793695-20110112-01. No abstract available.

PMID:
21323192
[PubMed - indexed for MEDLINE]
3.

Fear of hypoglycaemia in parents of young children with type 1 diabetes: a systematic review.

Barnard K, Thomas S, Royle P, Noyes K, Waugh N.

BMC Pediatr. 2010 Jul 15;10:50. doi: 10.1186/1471-2431-10-50. Review.

PMID:
20633252
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Cognitive function is disrupted by both hypo- and hyperglycemia in school-aged children with type 1 diabetes: a field study.

Gonder-Frederick LA, Zrebiec JF, Bauchowitz AU, Ritterband LM, Magee JC, Cox DJ, Clarke WL.

Diabetes Care. 2009 Jun;32(6):1001-6. doi: 10.2337/dc08-1722. Epub 2009 Mar 26.

PMID:
19324943
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial.

Kilpatrick ES, Rigby AS, Atkin SL.

Diabetes Care. 2008 Nov;31(11):2198-202. doi: 10.2337/dc08-0864. Epub 2008 Jul 23.

PMID:
18650371
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Assessment and management of hypoglycemia in children and adolescents with diabetes.

Clarke W, Jones T, Rewers A, Dunger D, Klingensmith GJ.

Pediatr Diabetes. 2008 Apr;9(2):165-74. doi: 10.1111/j.1399-5448.2008.00405.x. No abstract available.

PMID:
18416698
[PubMed - indexed for MEDLINE]
7.
8.

Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study.

Amin R, Widmer B, Prevost AT, Schwarze P, Cooper J, Edge J, Marcovecchio L, Neil A, Dalton RN, Dunger DB.

BMJ. 2008 Mar 29;336(7646):697-701. doi: 10.1136/bmj.39478.378241.BE. Epub 2008 Mar 18.

PMID:
18349042
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Effects of prior hypoglycemia and hyperglycemia on cognition in children with type 1 diabetes mellitus.

Perantie DC, Lim A, Wu J, Weaver P, Warren SL, Sadler M, White NH, Hershey T.

Pediatr Diabetes. 2008 Apr;9(2):87-95. doi: 10.1111/j.1399-5448.2007.00274.x. Epub 2008 Jan 12.

PMID:
18208449
[PubMed - indexed for MEDLINE]
10.

Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes.

Robertson KJ, Schoenle E, Gucev Z, Mordhorst L, Gall MA, Ludvigsson J.

Diabet Med. 2007 Jan;24(1):27-34.

PMID:
17227321
[PubMed - indexed for MEDLINE]
11.

A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes.

Hermansen K, Davies M, Derezinski T, Martinez Ravn G, Clauson P, Home P.

Diabetes Care. 2006 Jun;29(6):1269-74. Erratum in: Diabetes Care. 2007 Apr;30(4):1035.

PMID:
16732007
[PubMed - indexed for MEDLINE]
12.

Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group.

N Engl J Med. 2005 Dec 22;353(25):2643-53.

PMID:
16371630
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Hypoglycemia: a complication of diabetes therapy in children.

Ryan C, Gurtunca N, Becker D.

Pediatr Clin North Am. 2005 Dec;52(6):1705-33.

PMID:
16301090
[PubMed - indexed for MEDLINE]
14.

Insulin detemir used in basal-bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin.

De Leeuw I, Vague P, Selam JL, Skeie S, Lang H, Draeger E, Elte JW.

Diabetes Obes Metab. 2005 Jan;7(1):73-82.

PMID:
15642078
[PubMed - indexed for MEDLINE]
15.

Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association.

Silverstein J, Klingensmith G, Copeland K, Plotnick L, Kaufman F, Laffel L, Deeb L, Grey M, Anderson B, Holzmeister LA, Clark N; American Diabetes Association.

Diabetes Care. 2005 Jan;28(1):186-212. Review. No abstract available.

PMID:
15616254
[PubMed - indexed for MEDLINE]
16.

The mechanism of protraction of insulin detemir, a long-acting, acylated analog of human insulin.

Havelund S, Plum A, Ribel U, Jonassen I, Vølund A, Markussen J, Kurtzhals P.

Pharm Res. 2004 Aug;21(8):1498-504.

PMID:
15359587
[PubMed - indexed for MEDLINE]
17.

Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes.

Hermansen K, Fontaine P, Kukolja KK, Peterkova V, Leth G, Gall MA.

Diabetologia. 2004 Apr;47(4):622-9.

PMID:
15298338
[PubMed - indexed for MEDLINE]
18.

Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen.

Russell-Jones D, Simpson R, Hylleberg B, Draeger E, Bolinder J.

Clin Ther. 2004 May;26(5):724-36.

PMID:
15220016
[PubMed - indexed for MEDLINE]
19.

Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes.

Heise T, Nosek L, Rønn BB, Endahl L, Heinemann L, Kapitza C, Draeger E.

Diabetes. 2004 Jun;53(6):1614-20.

PMID:
15161770
[PubMed - indexed for MEDLINE]
Free Article
20.

Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes: a randomized clinical trial.

Home P, Bartley P, Russell-Jones D, Hanaire-Broutin H, Heeg JE, Abrams P, Landin-Olsson M, Hylleberg B, Lang H, Draeger E; Study to Evaluate the Administration of Detemir Insulin Efficacy, Safety and Suitability (STEADINESS) Study Group.

Diabetes Care. 2004 May;27(5):1081-7.

PMID:
15111525
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk